Abstract
Objective To estimate surge capacities and demands of Brazil’s health system in view of severe cases of the novel coronavirus disease.
Methods Three types of hospital equipments demanded by severe COVID-19 patients are considered: available intensive care unit (ICU) beds, existing surgery operating rooms and respirators located in other hospital areas. They are taken into account on a cumulative basis forming three levels of hospital equipment usage. Based on a mean duration of hospitalization for the disease, it is estimated the daily admission capacity of infected patients per state and for the entire country for each level of hospital equipment usage. Furthermore, an exponential regression model is fitted by means of the daily national number of new documented patients. The prediction intervals for the number of new patients for certain days in the immediate future are then calculated and compared to the admissible daily demand for the three incremental groups of equipments. The data are made publicly available by the Brazilian federal government and are gathered and analyzed by means of the Python programming language.
Results 41% of the (adult) ICU beds in Brazil were available during 2019, indicating that this hospital equipment has not been on average operating near capacity in national numbers. Nevertheless, there is a marked heterogeneity in the absolute and relative numbers of available and existing ICU beds and existing surgery operating rooms and extra respirators between its states.
Conclusions The remarkable differences between states’ hospital resources directly reflect into the number of possible daily admissions of COVID-19 patients with respiratory failure for the three considered levels of hospital equipment usage. In national numbers, Brazil’s health system is estimated to be capable of daily admitting 693, 1243 and 2166 severe patients under the three studied scenarios. The fitted model predicted that only the first limit, if any, would be reached.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The authors or their institutions did not receive payment or services from a third party for any aspect of the submitted work.
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data referred to in the manuscript are available on the internet for public downloading.
